143 related articles for article (PubMed ID: 19911992)
1. Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivir.
Koudstaal W; Koldijk MH; Brakenhoff JP; Cornelissen LA; Weverling GJ; Friesen RH; Goudsmit J
J Infect Dis; 2009 Dec; 200(12):1870-3. PubMed ID: 19911992
[TBL] [Abstract][Full Text] [Related]
2. The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses.
Paules CI; Lakdawala S; McAuliffe JM; Paskel M; Vogel L; Kallewaard NL; Zhu Q; Subbarao K
J Infect Dis; 2017 Aug; 216(3):356-365. PubMed ID: 28633457
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo.
Chen J; Yan B; Chen Q; Yao Y; Wang H; Liu Q; Zhang S; Wang H; Chen Z
Arch Virol; 2014 Mar; 159(3):471-83. PubMed ID: 24057757
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection.
Prabhu N; Prabakaran M; Ho HT; Velumani S; Qiang J; Goutama M; Kwang J
J Virol; 2009 Mar; 83(6):2553-62. PubMed ID: 19109379
[TBL] [Abstract][Full Text] [Related]
5. Humanized antibodies with broad-spectrum neutralization to avian influenza virus H5N1.
Chen Y; Luo W; Wu WL; Fang Z; Xia L; Gui X; Chen Y; Chen H; Shih JW; Xia N
Antiviral Res; 2010 Jul; 87(1):81-4. PubMed ID: 20450935
[TBL] [Abstract][Full Text] [Related]
6. New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets.
Friesen RH; Koudstaal W; Koldijk MH; Weverling GJ; Brakenhoff JP; Lenting PJ; Stittelaar KJ; Osterhaus AD; Kompier R; Goudsmit J
PLoS One; 2010 Feb; 5(2):e9106. PubMed ID: 20161706
[TBL] [Abstract][Full Text] [Related]
7.
Sutton TC; Lamirande EW; Bock KW; Moore IN; Koudstaal W; Rehman M; Weverling GJ; Goudsmit J; Subbarao K
J Virol; 2017 Dec; 91(24):. PubMed ID: 29046448
[TBL] [Abstract][Full Text] [Related]
8. An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses.
Oh HL; Akerström S; Shen S; Bereczky S; Karlberg H; Klingström J; Lal SK; Mirazimi A; Tan YJ
J Virol; 2010 Aug; 84(16):8275-86. PubMed ID: 20519402
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of new monoclonal antibodies against swine origin 2009 influenza A (H1N1) virus and evaluation of their prophylactic and therapeutic efficacy in a mouse model.
Wang SF; Tseng SP; Loh EW; Wang WH; Li MC; Chen KH; Tsai WC; Lee YM; Chen HY; Liu FT; Arthur Chen YM; Huang JC
Dev Comp Immunol; 2017 Feb; 67():8-17. PubMed ID: 27984103
[TBL] [Abstract][Full Text] [Related]
10. Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice.
Smee DF; Hurst BL; Wong MH; Bailey KW; Tarbet EB; Morrey JD; Furuta Y
Antimicrob Agents Chemother; 2010 Jan; 54(1):126-33. PubMed ID: 19901093
[TBL] [Abstract][Full Text] [Related]
11. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
[TBL] [Abstract][Full Text] [Related]
12. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
13. A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection.
Sakabe S; Iwatsuki-Horimoto K; Horimoto T; Nidom CA; Le Mt; Takano R; Kubota-Koketsu R; Okuno Y; Ozawa M; Kawaoka Y
Antiviral Res; 2010 Dec; 88(3):249-55. PubMed ID: 20849879
[TBL] [Abstract][Full Text] [Related]
14. Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries.
Kashyap AK; Steel J; Rubrum A; Estelles A; Briante R; Ilyushina NA; Xu L; Swale RE; Faynboym AM; Foreman PK; Horowitz M; Horowitz L; Webby R; Palese P; Lerner RA; Bhatt RR
PLoS Pathog; 2010 Jul; 6(7):e1000990. PubMed ID: 20628565
[TBL] [Abstract][Full Text] [Related]
15. An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection.
Zanin M; Keck ZY; Rainey GJ; Lam CY; Boon AC; Rubrum A; Darnell D; Wong SS; Griffin Y; Xia J; Webster RG; Webby R; Johnson S; Foung S
J Virol; 2015 Apr; 89(8):4549-61. PubMed ID: 25673719
[TBL] [Abstract][Full Text] [Related]
16. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
[TBL] [Abstract][Full Text] [Related]
17. Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.
Leyva-Grado VH; Tan GS; Leon PE; Yondola M; Palese P
Antimicrob Agents Chemother; 2015 Jul; 59(7):4162-72. PubMed ID: 25941218
[TBL] [Abstract][Full Text] [Related]
18. Cross-protective potential of anti-nucleoprotein human monoclonal antibodies against lethal influenza A virus infection.
Fujimoto Y; Tomioka Y; Takakuwa H; Uechi GI; Yabuta T; Ozaki K; Suyama H; Yamamoto S; Morimatsu M; Mai LQ; Yamashiro T; Ito T; Otsuki K; Ono E
J Gen Virol; 2016 Sep; 97(9):2104-2116. PubMed ID: 27260213
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses.
Kiso M; Kubo S; Ozawa M; Le QM; Nidom CA; Yamashita M; Kawaoka Y
PLoS Pathog; 2010 Feb; 6(2):e1000786. PubMed ID: 20195462
[TBL] [Abstract][Full Text] [Related]
20. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
Throsby M; van den Brink E; Jongeneelen M; Poon LL; Alard P; Cornelissen L; Bakker A; Cox F; van Deventer E; Guan Y; Cinatl J; ter Meulen J; Lasters I; Carsetti R; Peiris M; de Kruif J; Goudsmit J
PLoS One; 2008; 3(12):e3942. PubMed ID: 19079604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
